Effect of biologically active coating on biocompatibility of Nitinol devices designed for the closure of intra-atrial communications.

Kong, Xiangqing; Grabitz, R. G.; van Oeveren, W.; Klee, D.; van Kooten, T. G.; Freudenthal, F.; Qing, Ma; von Bernuth, G.; SEGHAYE, Marie-Christine

doi:10.1016/S0142-9612(01)00304-0

Article (Scientific journals)

Effect of biologically active coating on biocompatibility of Nitinol devices designed for the closure of intra-atrial communications.

Kong, Xiangqing; Grabitz, R. G.; van Oeveren, W. et al.

2002 • In Biomaterials, 23 (8), p. 1775-83

Peer Reviewed verified by ORBi

Permalink
https://hdl.handle.net/2268/112969

DOI
10.1016/S0142-9612(01)00304-0

PubMed
11950048

Files (1)Send to Details Statistics Bibliography Similar publications

Files

Full Text

Seghaye2002-Effect of biologically active coating on biocompatibility of Nitinol devices designed for the closure of intraatrial communications pdf.pdf

Publisher postprint (504.07 kB)

Request a copy

All documents in ORBi are protected by a user license.

Send to

RIS BibTex APA Chicago Permalink X Linkedin

Details

Keywords :

Alloys/chemistry; Animals; Biocompatible Materials; Blood Platelets/metabolism; Cells, Cultured; Endothelium, Vascular/cytology/metabolism; Fibronectins/chemistry; Hemolysis; Heparin/chemistry; Hirudins/chemistry; Humans; Immunohistochemistry; Microscopy, Confocal; Microscopy, Electron, Scanning; Partial Thromboplastin Time; Sheep; Tetrazolium Salts/pharmacology; Thiazoles/pharmacology; Umbilical Veins/metabolism

Abstract :

[en] Anti-thrombogenicity and rapid endothelialisation are prerequisites for the use of closure devices of intra-atrial communications in order to reduce the risk of cerebral embolism. The purpose of this study was therefore to assess the effect of bioactive coatings on biocompatibility of Nitinol coils designed for the closure of intra-atrial communications. Nitinol coils (n = 10, each) and flat Nitinol bands (n = 3, each) were treated by basic coating with poly(amino-p-xylylene-co-p-xylylene) and then coated with either heparin, r-hirudin or fibronectin. Anti-thrombogenicity was studied in vitro in a dynamic model with whole blood by partial thromboplastin time (PTT), platelet binding and thrombin generation, respectively, and cytotoxicity by hemolysis. Endothelialisation was studied on Nitinol bands with human umbilical venous endothelial cells (HUVEC) by 3-(4,5-dimethylthiazole-2yl)-2,5-triphenyl tetrazolium (MTT) assay and immnuofluorescence analysis of Ki67, vinculin, fibronectin and von Willebrand Factor. Uncoated or coated devices did not influence hemolysis and PTT. r-Hirudin (but not heparin) and fibronectin coating showed lower platelet binding than uncoated Nitinol (p < 0.005, respectively). Heparin and r-hirudin coating reduced thrombin formation (p < 0.05 versus Nitinol, respectively). HUVEC adhesion, proliferation, and matrix formation decreased in the order: fibronectin coating > uncoated Nitinol > r-hirudin coating > heparin coating > basic coating. MTT assay corroborated these findings. In conclusion, r-hirudin and fibronectin coating, by causing no acute cytotoxicity, decreasing thrombogenicity and increasing endothelialisation improve in vitro biocompatibility of Nitinol devices designed for the closure of intra-atrial communications.

Disciplines :

Pediatrics
Laboratory medicine & medical technology

Author, co-author :

Kong, Xiangqing; Rheinisch - Westfälische Technische Hochschule Aachen - RWTH > Pediatric Cardiology

Grabitz, R. G.; Rheinisch - Westfälische Technische Hochschule Aachen - RWTH > Pediatric Cardiology

van Oeveren, W.; University of Groningen, The Netherlands > Biomedical Engineering

Klee, D.; Rheinisch - Westfälische Technische Hochschule Aachen - RWTH > Institute of Macromolecular- and Textile Chemistry

van Kooten, T. G.; University of Groningen, The Netherlands > Biomedical Engineering

Freudenthal, F.; Rheinisch - Westfälische Technische Hochschule Aachen - RWTH > Pediatric Cardiology

Qing, Ma; Rheinisch - Westfälische Technische Hochschule Aachen - RWTH > Pediatric Cardiology

von Bernuth, G.; Rheinisch - Westfälische Technische Hochschule Aachen - RWTH > Pediatric Cardiology

SEGHAYE, Marie-Christine ; Rheinisch - Westfälische Technische Hochschule Aachen - RWTH > Pediatric Cardiology

Language :

English

Title :

Effect of biologically active coating on biocompatibility of Nitinol devices designed for the closure of intra-atrial communications.

Publication date :

April 2002

Journal title :

Biomaterials

ISSN :

0142-9612

eISSN :

1878-5905

Publisher :

Butterworth Heinemann, Oxford, United Kingdom

Volume :

Issue :

Pages :

1775-83

Peer reviewed :

Peer Reviewed verified by ORBi

Available on ORBi :

since 27 February 2012

Statistics

Number of views

73 (2 by ULiège)

Number of downloads

0 (0 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenCitations

Bibliography

Castleman L.S., Motzkin S.M., Alicandri F.P., Bonawit V.L. (1976) Biocompatibility of Nitinol alloy as an implant material. J Biomed Mater Res 10:695-731.
Barras C.D., Myers K.A. (2000) Nitinol - Its use in vascular surgery and other applications. Eur J Vasc Endovasc Surg 19(6):564-569.
Shabalovskaya S.A. (1996) On the nature of the biocompatibility and on medical applications of NiTi shape memory and superelastic alloys. Biomed Mater Eng 6(4):267-289.
De Scheerder I., Wang K., Wilczek K., Meuleman D., Van Amsterdam R., Vogel G., Piessens J., Van de Werf F. (1997) Experimental study of thrombogenicity and foreign body reaction induced by heparin-coated coronary stents. Circulation 95(6):1549-1553.
Phaneuf M.D., Berceli S.A., Bide M.J., Quist W.C., LoGerfo F.W. (1997) Covalent linkage of recombinant hirudin to poly(ethylene terephthalate) (Dacron): Creation of a novel antithrombin surface. Biomaterials 18(10):755-765.
Seeger J.M., Klingman N. (1988) Improved in vivo endothelialization of prosthetic grafts by surface modification with fibronectin. J Vasc Surg 8(4):476-482.
Lahann J., Klee D., Pluester W., Hoecker H. (2001) Bioactive immobilisation of r-hirudin on CVD-coated metallic implant devices. Biomaterials 22(8):817-826.
Lahann J., Klee D., Hoecker H. (1998) Chemical vapour deposition polymerisation of substituted [2.2]paracyclophanes. Macromol Rapid Comm 19:441-444.
Smith P.K., Mallia A.K., Hermanson G.T. (1980) Colorimetric method for the assay of heparin content in immobilized heparin preparations. Anal Biochem 109(2):466-473.
Karges H.E., Funk K.A., Ronneberger H. (1994) Activity of coagulation and fibrinolysis parameters in animals. Arzneimittelforschung 44(6):793-797.
Toes G.J., Van den Dungen J.J., Haan J., Hermens R.A., Van Oeveren W. (1999) Fluorescence labeling to study platelet and leucocyte deposition onto vascular grafts in vitro. Biomaterials 20(20):1951-1958.
Jaffe E.A., Nachman R.L., Becker C.G., Minick C.R. (1973) Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest 52(11):2745-2756.
La Rosee K., Deutsch H.J., Schnabel P., Schneider C.A., Burkhard-Meier C., Hopp H.W. (1999) Thrombus formation after transcatheter closure of atrial septal defect. Am J Cardiol 84(3):356-359.
Hung J., Landzberg M.J., Jenkins K.J., King M.E., Lock J.E., Palacios I.F., Lang P. (2000) Closure of patent foramen ovale for paradoxical emboli: Intermediate-term risk of recurrent neurological events following transcatheter device placement. J Am Coll Cardiol 35(5):1311-1316.
Van Kooten T.G., Klein C.L., Wagner M., Kirkpatrick C.J. (1999) Focal adhesions and assessment of cytotoxicity. J Biomed Mater Res 46(1):33-43.
Shih C.C., Lin S.J., Chen Y.L., Su Y.Y., Lai S.T., Wu G.J., Kwok C.F., Chung K.H. (2000) The cytotoxicity of corrosion products of Nitinol stent wire on cultured smooth muscle cells. J Biomed Mater Res 52(2):395-403.
Rhodes N.P., Williams D.F. (1994) Plasma recalcification as a measure of contact phase activation and heparinization efficacy after contact with biomaterials. Biomaterials 15(1):35-37.
Xiao M., Theroux P. (1998) Platelet activation with unfractionated heparin at therapeutic concentrations and comparisons with a low-molecular-weight heparin and with a direct thrombin inhibitor. Circulation 97(3):251-256.
Nishibe T., Okuda Y., Kumada T., Tanabe T., Yasuda K. (2000) Enhanced graft healing of high-porosity expanded polytetrafluoroethylene grafts by covalent bonding of fibronectin. Surg Today 30(5):426-431.
Axel D.I., Frigge A., Dittmann J., Runge H., Spyridopoulos I., Riessen R., Viebahn R., Karsch K.R. (2001) All-trans retinoic acid regulates proliferation, migration, differentiation, and extracellular matrix turnover of human arterial smooth muscle cells. Cardiovasc Res 49(4):851-862.
Raman V.K., Edelman E.R. (1998) Coated stents: Local pharmacology. Semin Interv Cardiol 3(3-4):133-137.
Kempczinski R.F., Ramalanjaona G.R., Douville C., Silberstein E.B. (1987) Thrombogenicity of a fibronectin-coated, experimental polytetrafluoroethylene graft. Surgery 101(4):439-444.
Bos G.W., Scharenborg N.M., Poot A.A., Engbers G.H., Beugeling T., Van Aken W.G., Feijen J. (1999) Blood compatibility of surfaces with immobilized albumin-heparin conjugate and effect of endothelial cell seeding on platelet adhesion. J Biomed Mater Res 47(3):279-291.
Castellot Jr. J.J., Cochran D.L., Karnovsky M.J. (1985) Effect of heparin on vascular smooth muscle cells. I. Cell metabolism. J Cell Physiol 124(1):21-28.
Nelson S.R., De Souza N.M., Allison D.J. (2000) Endovascular stents and stent-grafts: Is heparin coating desirable?. Cardiovasc Intervent Radiol 23:252-255.